sepsis
The company established its European office in Paris in 2018 and has worked to develop the market for its flagship dRAST platform in the region ever since.
Numerous technologies in development to help with the diagnosis of sepsis have a singular objective ─ detect the condition as quickly as possible.
Becton Dickinson, Siemens Healthineers, Abbott Laboratories, Others Nab FDA Clearances in November
BioMérieux obtained FDA clearance for a multiplex RT-PCR assay that detects SARS-CoV-2 RNA in nasopharyngeal swabs from symptomatic individuals.
Immunexpress Receives FDA 510(k) Clearance for Sepsis Assay
The assay, which runs on the company's Idylla platform, distinguishes sepsis from noninfectious systemic inflammation.
Prenosis Nabs Up to $4.3 Million From US DoD to Develop Early Sepsis POC Test
Prenosis will adapt its Immunix platform, which uses machine learning algorithms that leverage biological and clinical data for the early detection of sepsis.
Nov 15, 2021
Nov 10, 2021
Bluejay Diagnostics Prices $21.6M IPO
Nov 4, 2021
T2 Biosystems Q3 Revenues Jump 42 Percent
Oct 15, 2021
Oct 13, 2021
Prenosis, Roche Partner on Sepsis Detection
Sep 9, 2021
May 20, 2021